تفسیر‘‘محاسن التاویل’’ میں جلال الدین قاسمی کے منہج کا تحقیقی مطالعہ

Brought up in the context of a very critical time of Islamic history, Imām Muḥammad Jalāl’uddīn Qāsimī (1866-1914) played a vital role to reform and purify the ongoing mindset of the Muslims in Syria in his time. He was a man believed in an independent thinking in the light of the Qur’ān and Sunnah. He taught the people to get rid of the backwardness and blind imitation (Taqlīd). For this purpose of his, he presented the works of the previous leading Islamic Scholars as they were. He was expert in various fields of knowledge like Qur’ān, Ḥadīth and their Sciences, Jurisprudence, Dialectic, etc. One of his masterpieces is his exegesis known as “Maḥāsin al-Tāwīl”. It is a great exegetical work; as most of the exegetical aspects are entertained in it. It has nine or seventeen volumes according to its two different editions, including a whole volume of preamble containing eleven Rules of Quranic Sciences. Although the critics object to his copying the long paragraphs of the prominent Islamic Scholars without commenting or editing and on his long discussions that deviate the reader from the actual purpose of the Holy Qur’ān, but to present the material in this way for the purpose of reformations of Muslims and to bring them back to the way of Salaf through their words, in that crucial time, justifies the significance of the work. In this article, the author probes to present the mythology adopted by Imām Qāsimī in his exegesis and its scholarly merits.

Two to Nine Year Review of Breast Conservation Therapy Bct for Breast Carcinoma: Clinico-Pathological Features and Survival in a Single Centre in East Africa

Introduction: Breast conservation therapy compares to mastectomy in terms of overall survival and disease free survival. However it’s utilization in most parts of the sub-Sahara Africa is minimal with various factors cited: patient preference, provider preference and adverse effects of or limited access to radiation therapy. The aim of this study was to determine the clinico-pathological profile and outcomes of breast cancer patients treated with breast conservation therapy or mastectomy at a single referral centre. Methods: The Aga khan university hospital is one of the institutions in East Africa, where breast conservation therapy is practiced. We retrospectively analysed the details of breast cancer patients who underwent breast conservation therapy from the year 2008 to 2015 and compared this with patients who had undergone mastectomy during the same period. Results: Ninety one patients who had breast conservation therapy and 187 patients who underwent mastectomy were included in this study. The following factors were correlated with the type of surgery: age <35, 35-50, >51 years, parity, grade, stage, histological subtype, receptor status, neo-adjuvant therapy, adjuvant therapy and re-excision rate. The majority of patients, 38.1% (n=106) had stage II breast cancer. Although there was no stage to stage comparison between the breast conservation group and the mastectomy group, patients who had breast conservation were likely to be younger, with tumour grade I or III and luminal A molecular subtype. There was no significant correlation with being nulliparous, grade II tumours, having received neoadjuvant chemotherapy or re-excision rates. Patients who had mastectomy were likely to be older with grade II breast cancer and had adjuvant chemotherapy. Conclusion: The present study concluded that with proper pre-operative patient selection, breast conservation therapy has comparable clinico-pathological characteristics and outcomes to mastectomy.